MedTrace Logo

A Pilot Study to Assess the Safety Profile of resB®

NCT05173168 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 22

Last updated 2022-04-29

No results posted yet for this study

Summary

The study investigates the safety and tolerability of 4-week, twice daily supplementation of resB® Lung Support in asthma patients and healthy participants.

Conditions

Interventions

DIETARY_SUPPLEMENT

Probiotic Dietary Supplement

Probiotic dietary supplement containing 3 probiotic strains and 3 herbal extracts

Sponsors & Collaborators

  • Atlantia Food Clinical Trials

    collaborator INDUSTRY

  • ResBiotic Nutrition, Inc.

    lead INDUSTRY

Principal Investigators

  • Timothy Dinan · Atlantia Food Clinical Trials

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-11-23
Primary Completion
2022-01-20
Completion
2022-01-20

Countries

  • Ireland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05173168 on ClinicalTrials.gov